Overall accuracy for any stage of pancreatic cancer improved from 82.7% with the CA19-9 protein alone to 91.9% with the ...
A new blood test that uses artificial intelligence (AI) may offer a faster, more accurate way to determine whether pancreatic cancer treatment is working. Known as ARTEMIS-DELFI, the test detects DNA ...
A new blood test could diagnose pancreatic cancer much earlier, improving survival rates for people with the disease. A large part of the reason for this poor prognosis is that pancreatic cancer is ...
A four-biomarker blood panel of aminopeptidase N (ANPEP), polymeric immunoglobulin receptor (PIGR), CA19-9, and ...
Scientists from Oregon Health & Science University have developed a blood test called PAC-MANN that is said to be less invasive, cheaper and more robust than traditional screening methods for ...
(CNN) — To spot breast cancer early, there are mammograms. To find colon cancer early, there are colonoscopies. But there is no standard test to detect early cases of pancreatic cancer, before cancer ...
Pancreatic cancer has a low survival rate and is usually found too late — this new test may help change that Researchers have ...
An experimental blood test for pancreatic cancer is being evaluated by a commercial laboratory, an important milestone toward making the test available for patients. An experimental blood test for ...
Knowable Magazine reports on advancements in pancreatic cancer treatment, including new drugs, vaccines, and early diagnostic ...
Pancreatic elastase is the digestive enzyme the pancreas produces to help digest food. Doctors can measure elastase levels by testing a stool sample. Low levels could indicate exocrine pancreatic ...
Editor’s note: The “Research Spotlight” series is written by Dr. Anna Berkenblit, PanCAN’s Chief Scientific and Medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results